Oculis Holding AG

XNAS:OCS   4:00:00 PM EDT
29.49
-1.51 (-4.87%)
4:38:12 PM EDT: $29.50 +0.01 (+0.03%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.60B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.23 Million
Adjusted EPS-$0.51
See more estimates
10-Day MA$29.51
50-Day MA$27.60
200-Day MA$23.08
See more pivots

Oculis Holding AG Stock, XNAS:OCS

Bahnhofstrasse 7, Bat D 3e Route J-D. Colladon, Zug, Zug 6300
Switzerland
Phone: +41.58.810.01.82
Number of Employees: 49

Description

Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improving eye care. The firm's pipeline includes multiple product candidates in development such as, OCS-01, a topical retinal candidate for diabetic macular edema, OCS-02, a topical biologic candidate for dry eye disease, and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company was founded in 2016 and is headquartered in Zug, Switzerland.